Sixteen N-phenylphthalimide derivatives were synthesized and their ability to inhibit alpha-glucosidase was investigated. N-(2,4-dinitrophenyl)phthalimide was a potent inhibitor of yeast alpha-glucosidase (IC50; 0.158 +/- 0.005 mM) and maltase (IC50; 0.051 +/- 0.008 mM), whereas it did not inhibit sucrase. From a Lineweaver-Burk plot of alpha-glucosidase kinetics, N-(2,4-dichlorophenyl)phthalimide was found to be a competitive inhibitor of yeast alpha-glucosidase. These results indicate that N-(2,4-dinitrophenyl)phthalimide could be a representative of a new group of alpha-glucosidase inhibitors.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/BF02977317 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Triflic Acid-Mediated Condensation of Phthalimide with Diaryl Ethers as a Route to Spiro-Isoindolinones: Mechanistic Insights and Related Reactions.
J Org Chem
November 2024
Boreskov Institute of Catalysis, Pr. Akademika Lavrentieva 5, Novosibirsk 630090, Russia.
Phthalimide and -phenylphthalimide smoothly condense with di--tolyl ether in triflic acid (CFSOH, TfOH) to obtain the corresponding spiro[isoindoline-1,9'-xanthen]-3-ones. Structural analogs of phthalimide, such as phthalic anhydride and 1,3-indandione (but not saccharin), show similar reactivity. In contrast, N-(tetrafluoropyridin-4-yl)phthalimide reacts with DTE by an alternative pathway, yielding isobenzofuran dispiro derivative.
View Article and Find Full Text PDFTwo-Ply Composite Membranes with Separation Layers from Chitosan and Sulfoethylcellulose on a Microporous Support Based on Poly(diphenylsulfone-N-phenylphthalimide).
Molecules
December 2017
Institute of Macromolecular Compounds of the Russian Academy of Sciences, Bolshoi pr. VO 31, St. Petersburg 199004, Russia.
Two-ply composite membranes with separation layers from chitosan and sulfoethylcellulose were developed on a microporous support based on poly(diphenylsulfone--phenylphthalimide) and investigated by use of X-ray diffraction and scanning electron microscopy methods. The pervaporation properties of the membranes were studied for the separation of aqueous alcohol (ethanol, propan-2-ol) mixtures of different compositions. When the mixtures to be separated consist of less than 15 wt % water in propan-2-ol, the membranes composed of polyelectrolytes with the same molar fraction of ionogenic groups (-NH₃⁺ for chitosan and -SO₃ for sulfoethylcellulose) show high permselectivity (the water content in the permeate was 100%).
View Article and Find Full Text PDFStructure-activity relationships for lipoprotein lipase agonists that lower plasma triglycerides in vivo.
Eur J Med Chem
October 2015
Department of Chemistry, Umeå University, SE-901 87 Umeå, Sweden; Laboratories for Chemical Biology Umeå, Chemical Biology Consortium Sweden, Umeå University, SE-901 87 Umeå, Sweden. Electronic address:
The risk of cardiovascular events increases in individuals with elevated plasma triglyceride (TG) levels, therefore advocating the need for efficient TG-lowering drugs. In the blood circulation, TG levels are regulated by lipoprotein lipase (LPL), an unstable enzyme that is only active as a non-covalently associated homodimer. We recently reported on a N-phenylphthalimide derivative (1) that stabilizes LPL in vitro, and moderately lowers triglycerides in vivo (Biochem.
View Article and Find Full Text PDFDevelopment of tryptase inhibitors derived from thalidomide.
Bioorg Med Chem
July 2010
Institute of Molecular & Cellular Biosciences, The University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-0032, Japan.
A novel series of tryptase inhibitors with a N-phenylphthalimide skeleton structurally derived from thalidomide (1) has been developed. Structure-activity relationship studies led to a potent and selective tryptase inhibitor, 2-(4-cyanophenyl)isoindole-1,3-dione-5-yl 3-(2-aminopyridin-5-yl)propanoate (7), with the IC50 value of 78 nM.
View Article and Find Full Text PDFGlycogen phosphorylase a inhibitors with a phenethylphenylphthalimide skeleton derived from thalidomide-related alpha-glucosidase inhibitors and liver X receptor antagonists.
Biol Pharm Bull
September 2009
Institute of Molecular & Cellular Biosciences, The University of Tokyo, Yayoi, Bunkyo-ku, Japan.
Novel glycogen phosphorylase a (GPa) inhibitors with a phenethylphenylphthalimide skeleton were prepared based on alpha-glucosidase inhibitors and liver X receptor (LXR) antagonists derived from thalidomide. Their structure-activity relationships were analyzed. Some of the compounds thus prepared showed potent inhibitory activity against rabbit muscle GPa with more than 10-fold greater efficacy than a typical GPa inhibitor, 1,4-dideoxy-1,4-imino-D-arabinitol.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!